Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2
- PMID: 11124893
- DOI: 10.1006/mcne.2000.0914
Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2
Abstract
Degeneration of dopaminergic neurons and focal gliosis are pathological hallmarks of Parkinson's disease and although the brain is described as immune-privileged focal immune reactions surround failing nigral neurons. We examined the cellular distribution of pro- and anti-inflammatory molecules in human parkinsonian and neurologically normal substantia nigra and caudate-putamen postmortem. An up-regulation of nitric oxide synthase- and cyclo-oxygenase-1- and -2-containing amoeboid microglia was found in parkinsonian but not control nigra. Astroglia contained low levels of these molecules in both groups. Lipocortin-1-immunoreactive amoeboid microglia were present within the astrocytic envelope of neurons adjacent to or within glial scars in parkinsonian nigra only. Lipocortin-1 is known to have neuroprotective and anti-inflammatory properties. Up-regulation of nitric oxide synthase is generally associated with neurodestruction whereas prostaglandin synthesis may be either neurodestructive or protective. The balance of these molecules is likely to be decisive in determining neuronal survival or demise.
Similar articles
-
Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.Glia. 2003 May;42(3):307-13. doi: 10.1002/glia.10225. Glia. 2003. PMID: 12673835
-
Neuroinflammatory processes in Parkinson's disease.Ann Neurol. 2003;53 Suppl 3:S49-58; discussion S58-60. doi: 10.1002/ana.10481. Ann Neurol. 2003. PMID: 12666098 Review.
-
Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration.Neurobiol Dis. 2003 Feb;12(1):35-45. doi: 10.1016/s0969-9961(02)00017-7. Neurobiol Dis. 2003. PMID: 12609487
-
p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.Neurosci Lett. 2007 Feb 27;414(1):94-7. doi: 10.1016/j.neulet.2006.12.003. Epub 2006 Dec 29. Neurosci Lett. 2007. PMID: 17196747
-
Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation.Cell Tissue Res. 2004 Oct;318(1):149-61. doi: 10.1007/s00441-004-0944-0. Epub 2004 Aug 24. Cell Tissue Res. 2004. PMID: 15338271 Review.
Cited by
-
Aquilariae Lignum Methylene Chloride Fraction Attenuates IL-1β-Driven Neuroinflammation in BV2 Microglial Cells.Int J Mol Sci. 2020 Jul 30;21(15):5465. doi: 10.3390/ijms21155465. Int J Mol Sci. 2020. PMID: 32751738 Free PMC article.
-
Annexin A1 translocates to nucleus and promotes the expression of pro-inflammatory cytokines in a PKC-dependent manner after OGD/R.Sci Rep. 2016 Jul 18;6:27028. doi: 10.1038/srep27028. Sci Rep. 2016. PMID: 27426034 Free PMC article.
-
A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson's disease: beneficial or detrimental effects.Inflammopharmacology. 2023 Apr;31(2):673-688. doi: 10.1007/s10787-023-01192-2. Epub 2023 Mar 24. Inflammopharmacology. 2023. PMID: 36961665 Review.
-
Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease.Neurobiol Aging. 2014 May;35(5):1162-76. doi: 10.1016/j.neurobiolaging.2013.10.077. Epub 2013 Oct 21. Neurobiol Aging. 2014. PMID: 24315037 Free PMC article.
-
Regulatory effects of fisetin on microglial activation.Molecules. 2014 Jun 26;19(7):8820-39. doi: 10.3390/molecules19078820. Molecules. 2014. PMID: 24972270 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials